
Sign up to save your podcasts
Or
#835B: Dr Sharon L. Campbell, DVM, MS, DACVIM, is the Medical Affairs Lead on Canine Chronic Pain at Zoetis, where they have developed Librela, a once-monthly injectable monoclonal antibody treatment for the control of canine osteoarthritis, since 40% of dogs of ALL ages have signs of OA.
3.9
1717 ratings
#835B: Dr Sharon L. Campbell, DVM, MS, DACVIM, is the Medical Affairs Lead on Canine Chronic Pain at Zoetis, where they have developed Librela, a once-monthly injectable monoclonal antibody treatment for the control of canine osteoarthritis, since 40% of dogs of ALL ages have signs of OA.
3,888 Listeners
90,648 Listeners
16,498 Listeners
77,550 Listeners
3 Listeners
3 Listeners
40 Listeners
7,711 Listeners
1,546 Listeners
9 Listeners
12,921 Listeners
43,364 Listeners
111,397 Listeners
14,228 Listeners
4,307 Listeners
5,098 Listeners
20,524 Listeners